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Abstract
Background: Medical students come into contact with infectious diseases early on their career.
Immunity against vaccine-preventable diseases is therefore vital for both medical students and the
patients with whom they come into contact.
Methods: The purpose of this study was to compare the medical history and serological status of
selected vaccine-preventable diseases of medical students in Germany.
Results: The overall correlation between self-reported medical history statements and serological
findings among the 150 students studied was 86.7 %, 66.7 %, 78 % and 93.3 % for measles, mumps,
rubella and varicella, conditional on sufficient immunity being achieved after one vaccination.
Although 81.2 % of the students' medical history data correlated with serological findings, significant
gaps in immunity were found.
Conclusion: Our findings indicate that medical history alone is not a reliable screening tool for
immunity against the vaccine-preventable diseases studied.
Background
Medical students are often exposed to infectious diseases
in the course of their clinical training.
It is therefore important to identify and limit any possible
gaps in immunity of vaccine-preventable diseases before
initial patient contact [1,2]. Reports by Breuer [3] confirm
that health care workers (HCWs) and medical students are
also a source of infection for patients. HCWs and their
employers should therefore be responsible for protecting
health care personnel and patients against hospital infec-
tions [4-7].
The Standing Committee on Vaccination (STIKO) at the
German Robert Koch-Institute (RKI) has recommended
two doses of MMR vaccine to all children to prevent out-
breaks of measles, mumps and rubella. The first dose
should be given at 11–14 months, the second vaccination
at 15–23 months. In 2006, the STIKO issued a recommen-
dation for one dose of varicella vaccine to be given univer-
sally to children at 11–14 month. HCWs without evidence
of immunity should have one dose of MMR and two
doses of varicella vaccination.
It is in the interests of the medical students to know their
own immune status against the immunisable viral infec-
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tions, but the individual student cannot be forced to
undergo vaccination. However, faculty has to bear the
costs of required vaccinations.
The purpose of this study was to compare the medical his-
tory with the serological status of selected vaccine-pre-
ventable viral diseases (measles, mumps, rubella and
varicella) of medical students in their first clinical semes-
ter at the Johann Wolfgang Goethe-University in Frank-
furt, Germany. The aim was to determine whether a
serological examination of the immune status was
required before vaccination or if a self-reported medical
history report alone was sufficient. The main focus was on
epidemiological and economical factors.
Methods
Study Group
At the Johann Wolfgang Goethe-University, 270 medical
students (172 [63.7 %] females; 98 [36.3 %] males) were
enrolled in their first clinical semester in October 2005.
The students were informed about the study in a lecture.
Overall, 150 (55.6 %) students (110 [73.3 %] females; 40
[26.7 %] males) completed the standardised question-
naire and took part in the study. Individuals with
unknown histories were not included in the study group.
The median age was 23.4 years (range 20 – 45 years).
Data were obtained by a voluntary questionnaire. Before
the study was carried out, the head of the Ethics Committee
of the University hospital Frankfurt confirmed, that there
was no special ethical approval required, because the eval-
uation of our study data was totally anonymous and there
were no additional blood samples necessary. We can con-
firm that participants cannot be identified from the mate-
rial presented and that no plausible harms to participating
individuals arise from the study.
Serological Tests
Serological tests were carried out for varicella zoster virus
(VZV), measles, mumps and rubella. Rubella specific IgG-
antibodies were tested by means of the Rubella IgG-MEIA-
assay (AxSYM system, Abbott Diagnostics Divison, Wies-
baden, Germany). Anti-measles virus-IgG, anti-mumps-
IgG, and anti-VZV-IgG were determined by means of
Enzygnost® Anti-Measles Virus-IgG, Enzygnost® Anti-Paro-
tis Virus-IgG, or Enzygnost® Anti-VZV-IgG (all from Dade
Behring, Marburg, Germany) respectively in the Behring
ELISA processor BEP 2000. Test results were recorded as
positive, borderline or negative, as outlined by the manu-
facturers. The sensitivity and specificity of the tests were
detailed by the manufactures as follows: 98.0 %, 99.0 %
(Rubella IgG-MEIA); 99.6 %, 100.0 % (Enzygnost® Anti-
Measles Virus-IgG); 95.4 %, 93.7 % (Enzygnost® Anti-Par-
otis Virus-IgG); and 99.3 %, 100.0 % (Enzygnost® Anti-
VZV-IgG).
As regards measles, mumps and VZV, clear positive anti-
body results (quantified in international units per litre
[IU/ml]) indicate a humoral immunity; borderline sero-
logical test results show an insufficient humoral immu-
nity and consequential, seronegative indicate no
detectable humoral immunity. Students with borderline
or negative serological results were assessed as "non-
immune" and were vaccinated.
Rubella-specific antibody measurement was carried out
with an ELISA. In the case of low-level immunity, a
hemagglutination inhibition assay (HI) was also per-
formed. HI-titres of 1: ≥ 32 or ELISA values ≥ 35 IU/l indi-
cate sufficient rubella immunity, low level immunity was
defined by a titre of 1:16 (HI) or ELISA values between
20–35 IU/l. HI-titres ≤ 1:8 or ELISA values of 1:<20 IU/l
were assessed as "non-immune".
Medical history data
The students recorded their vaccination status (date and
total number of vaccinations) against measles, mumps,
rubella and varicella by means of a standardised question-
naire (Fig. 1). Self-reported medical history data regarding
infection with the relevant viruses was also documented.
The reliability of the self-reported medical history state-
ments was compared with the serological findings. For
purposes of these analyses, students claiming "don't
know" for history of disease or vaccination were excluded,
only documentary evidence was accepted for a history of
vaccination.
Correlation factor
The overall correlation (in %) of the medical history with
the serological results was evaluated as followed:
Either
- sufficient immunity was achieved by a single vaccina-
tion, or
- insufficient immunity followed a single vaccination. In
this case, borderline and negative serological results were
recorded as non-immune and compatible with the medi-
cal history, while positive results were recorded as incom-
patible with the medical history.
Predictive value
Positive predictive value (PPV): The reliability of a positive
history of disease or vaccination in predicting immunity.
Negative predictive value (NPV): The reliability of a nega-
tive self-reported history of disease or vaccination in pre-
dicting susceptibility.BMC Public Health 2008, 8:121 http://www.biomedcentral.com/1471-2458/8/121
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Results
The overall correlation between medical history state-
ments and serological findings among the 150 students
studied was 86.7 %, 66.7 %, 78 % and 93.3 % for measles,
mumps, rubella and varicella, provided that sufficient
immunity was achieved after a single vaccination.
Measles-specific antibodies could be identified in 94 % of
the students (n = 141), with 86 % (n = 129) achieving suf-
ficient immunity, 8 % (n = 12) with insufficient immunity
(measles virus IgG borderline values) and 6 % (n = 9) with
no immunity (Fig. 2). The medical history statements
showed that 46 % of the students (n = 69) had had either
at least two measles vaccinations (n = 62) or measles itself
(n = 7). About 14.5 % (n = 10) of them showed either an
Questionnaire for medical students Figure 1
Questionnaire for medical students.
Questionnaire for Medical Students 
(all data will be treated with confidentiality)
Last Name:         First Name:               DOB: 
Address:          Zip, City:  
Semester:            Tel.: 
Previous Work with Danger of Infection (including temporary work, civil service, volunteer social year, etc.)
Activities / Workplace  from:             to: 
Previous Illnesses (especially chronic illnesses and infections, skin diseases, lung diseases, etc.):
Do you currently have health complaints?                                                    Yes          No 
If yes, which: 
Vaccinations Number Date/Year of the last vaccine   Year of having had the disease  
Rubella
Measles
Mumps
Chicken Pox 
Date          Signature BMC Public Health 2008, 8:121 http://www.biomedcentral.com/1471-2458/8/121
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insufficient or total lack of immunity serologically.
Among the seven students who reported having had nei-
ther measles nor a vaccination against it, three were suffi-
ciently immune in the serological test (Tab. 1).
Probability estimates are presented in Table 2.
Mumps-specific antibodies were detected in 85.3 % (n =
128) of the students. In detail: 66 % (n = 99) had suffi-
cient immunity, 19.3 % (n = 29) had insufficient immu-
nity (mumps virus IgG borderline values) and 14.7 % (n
= 22) had no immunity (Fig. 2). The correlation with the
data from the questionnaire showed that 17.2 % (n = 11)
of the students who reported having had either at least
two mumps vaccinations (n = 56) or mumps itself (n = 8)
had serologically an insufficient immunity or none at all.
Among the 10 students who reported having had neither
mumps nor a mumps vaccination, four showed a suffi-
cient immunity (Tab. 1). The overall correlation between
the serological and medical history data for mumps
immunity was 66.7 %, provided that sufficient immunity
was achieved after a single vaccination.
Rubella-specific antibodies could be found in 92.7 % of
the students (n = 139), with 82 % (n = 123) having suffi-
cient immunity (IgG ≥ 35 IU/l), 10.7 % (n = 16) having
low-level immunity (IgG ≥ 20 - <35 IU/l), and 7.3 % (n =
11) completely non-immune (Fig. 2). Insufficient or a
total lack of immunity was shown in 20.6 % (n = 14) of
the students who reported either at least two rubella vac-
cinations (n = 51) or having had the german measles itself
(n = 17). Among the 10 students who reported having had
neither rubella nor a vaccination against it, eight students
showed sufficient immunity (Tab. 1).
With regards to varicella serology, 99.3 % (n = 149) of the
students showed specific antibodies. In detail: 97.3 % (n
= 146) of the students showed sufficient varicella immu-
nity, 2 % (n = 3) had an insufficient immunity (borderline
values: 100 – 150 IU/l) and one student (0.7 %) was
seronegative (Fig. 2). Based on self-reported medical his-
tory data, 144 students (96 %) reported having had
chicken pox in their childhood, none had a history of a
VZV vaccination, four (2.6 %) showed an insufficient or
lack of immunity serologically. Six students (4 %) who
could not remember having had chicken pox showed suf-
ficient VZV immunity serologically. To summarise, the
self-reported medical history statements of 140 (93.3 %)
students correlated with the serological findings (Tab. 1).
Self-reported history of varicella had a high PPV (99.3%)
Measles, mumps, rubella and VZV-seroprevalence (n = 150) Figure 2
Measles, mumps, rubella and VZV-seroprevalence (n = 150).
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
measles mumps rubella varicella
sufficient immunity insufficient / low-level immunity  no immunity
Prevalence [%]BMC Public Health 2008, 8:121 http://www.biomedcentral.com/1471-2458/8/121
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for a test result positive for anti-varicella virus antibodies
(Tab. 2).
Overall, 81.2 % of the students' medical history data cor-
related with serological results, thus significant gaps in
immunity were found.
Discussion
Medical students come into contact with infectious dis-
eases early on their career [4,5].
The aim of our study was to determine whether the data
of a standardised questionnaire about the medical history
correlated with serological results. In the event of a high
correlation rate the necessity of vaccinations would be
demonstrated by the questionnaire alone, thereby avoid-
ing cost-intensive serological analysis. In view of limited
financial budgets in the public health system, economical
aspects – such as the avoidance of serological analysis or
vaccinations – should be given serious consideration
[8,9].
The serological results of our study showed that 14 % of
the students had insufficient measles immunity or were
totally non-immune. For mumps, rubella and chicken-
pox, 34 %, 18 % and 2.7 % had insufficient or no immu-
nity. The serological data in this study is similar to data
from a non-student study of a comparable age group (20
– 29 years) from the University Hospital of Frankfurt [10]
as well as to results from studies on medical students at
the University of Frankfurt [11] and Basel [2].
With regards to the sensitivity of the assays used, it should
be taken into account that false negative ELISA results
Table 1: Correlation of the medical history of vaccination or virus-specific disease and serological results (n = 150)
measles mumps
serological results serological results
no. of students positive borderline negative no. of students positive borderline negative
History of disease 7 502 8 701
History of at least 2 vaccinations 62 54 7 1 56 46 7 3
History of 1 vaccination 74 67 5 2 76 42 21 13
No history of disease or vaccination 7 304 10 415
Overall correlation (in %) of serological results and medical 
history data (conditional on sufficient immunity being achieved 
after a single vaccination)
150 86.7 % 150 66.7 %
Overall correlation (in %) of serological results and medical 
history data (insufficient immunity following one vaccination 1)
150 46.7 % 150 61.3 %
rubella varicella
serological results serological results
no. of students positive borderline negative no. of students positive borderline negative
History of disease 17 15 0 2 144 140 3 1
History of at least 2 vaccinations 51 39 12 0 0 000
History of 1 vaccination 72 61 4 7 0 000
No history of disease or vaccination 10 802 6 600
Overall correlation (in %) of serological results and medical 
history data (conditional on sufficient immunity being achieved 
after a single vaccination)
150 78 % 150 93.3 %
Overall correlation (in %) of serological results and medical 
history data (insufficient immunity following one vaccination 1)
150 44.7 % 150 93.3 %
1borderline and negative results are assessed as correlating to the medical history data
Table 2: Positive predictive value (PPV) of self-reported History 
of Disease (HD) or Vaccination against Disease (HV) in 
predicting immunity (n = 150). HV one: one vaccination, HV two: 
two vaccinations
PPV
Measles
HD 71.4%
HV one 97.3%
HV two 98.4%
Mumps
HD 87.5%
HV one 82.9%
HV two 94.6%
Rubella
HD 88.2%
HV one 88.5%
HV two 100.0%
Varicella
HD only 99.3%BMC Public Health 2008, 8:121 http://www.biomedcentral.com/1471-2458/8/121
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might distort the actual rate of humoral immunity [12].
These assays are nevertheless commonly used as screening
tests to determine immunity status because they are less
labor- and time-intensive than cell culture-based neutral-
isation assays which detect neutralising antibodies. Inter-
national antibody standards exist for measles and rubella
but not for mumps. Compared with neutralisation assays,
up to 30 % of ELISA false negative mumps antibody
results were recorded [12]. This is often due to the rela-
tively high serum-dilution factors used in ELISA tests.
Nevertheless, it is clear from the study that it is vital to
assure total immunity before initial patient contact. This
is important not only for the students' individual protec-
tion but also for the prevention of hospital infections [13-
16].
From an economical point of view three different vaccina-
tion strategies are possible:
1. Serological testing of all students, elimination of indi-
vidual gaps in immunity.
2. Recording medical students' past viral diseases or vacci-
nations, elimination of lapses in immunity.
3. Vaccination of all students without prior serological
testing or reports (In this case, it should be taken into con-
sideration that the administration of an attenuated live
vaccine to a large patient population may result in side
effects and thereby reduce the acceptance rate of vaccina-
tions).
The conformity of the results of the questionnaire with the
serological data was moderate to unsatisfactory. For mea-
sles, mumps, rubella and VZV the total correlation rate
was 86.7 %, 66.7 %, 78 % and 93.3 %, provided that suf-
ficient immunity was achieved after a single vaccination.
This assumption is backed up by data from the WHO
which indicate that 85 – 90 % of people who receive a sin-
gle dose of the measles vaccine show a sufficient immu-
nity [17]. For rubella, mumps and VZV, a single dose
vaccine achieves immunity of ≥ 95 %, 75–99 % and 95 %
of the recipients [18-20].
The present study shows that 14.5 % of the students who
reported having had two measles vaccinations or measles
itself showed insufficient or no immunity serologically.
This was also valid for 17.2 % of the students regarding
mumps. In the case of the mumps ELISA, the limited sen-
sitivity of the assay should be taken into consideration
[12]. Assuming that borderline ELISA results are likely
representing immunity, instead of 17.2 %, only 6.3 % of
those students would show no immunity. Additionally,
the overall correlation between the serological results and
the medical history data would increase to 85.3 %.
In the case of rubella and VZV, 20.6 % and 2.8 % of the
students who reported having had at least two rubella vac-
cinations, rubella itself or chickenpox did not show a suf-
ficient immunity serologically. If the students' self-
reported medical history data is correlated with the sero-
logical results, it should be taken into account that the
reliability of information based on history about the spe-
cific aetiology of a disease might limited [21]. The fact that
different parameters such as test sensitivity or reliability of
information based on history might influence the correla-
tion should certainly be taken into account.
Overall, self-reported history of varicella and measles had
a higher PPV (99.3%; 96.5% respectively) than self-
reported history of rubella (93.6%) and mumps (87.8). In
addition, self-reported history of vaccinations against
measles, mumps and rubella had a higher PPV than self-
reported history of these diseases and two vaccinations
had a higher PPV than one vaccination.
Similar data of PPV were published in several other stud-
ies, which showed that reliability upon historical informa-
tion alone is inadequate to identify all susceptible
individuals [22-24]. For this reason, it was decided, at
Frankfurt university hospital, to continue the serological
testing of all medical students. Based on the test results,
individual gaps in immunity can be closed with vaccina-
tion.
However, among HCWs at occupational risk of viral
immunisable diseases, the need for vaccination can be
reduced by combining historical and serological screening
[25]. Nevertheless, using only data based on history as a
criterion of immunity to immunisable viral diseases,
would not achieve the goal of reducing susceptibility to
zero in the medical student population [23].
Conclusion
Our study indicates that a students' medical history alone
is not a reliable screen for determining immune status for
the vaccine-preventable diseases studied.
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